Grants / Department of Defense / Defense Health Agency Contracting Activity - DHACA

W81XWH-21-ERP-IDA: DoD Epilepsy, Idea Development Award

Closed Closed July 21, 2021 Opportunity W81XWH-21-ERP-IDA ☆ Save

This grant is closed. A newer notice from the same program is open now: DoW Breast Cancer, Clinical Research Extension Award (HT942526BCRPCREA2). Status: Closes November 18, 2026 (11 days left). It is in our archive of Defense Health Agency Contracting Activity - DHACA notices from 2021.

• Total funding$3.4 million
• Expected awards5
• Cost sharingNot required
• Funding typeCooperative Agreement, Grant

Key dates

Who can apply

This opportunity was open to any type of organization.

• Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

More grants for nonprofits, colleges and universities, state and local governments, tribes, small businesses, businesses, individuals.

Is this a realistic fit?

• Most of the program's money (59% over five years) went to colleges and universities.
• No cost sharing or match is required.

What the grant funds

The intent of the FY21 ERP IDA is to solicit novel, innovative research to understand the magnitude and underlying mechanisms of PTE related to the ERP’s mission (see Section II.A, Program Description). The work should innovatively challenge existing research paradigms or exhibit high levels of creativity within the contexts of the ERP’s mission and vision. The application should also demonstrate the study team’s experience in PTE research, as appropriate. The innovation and impact for the FY21 ERP IDA are expected to benefit the military, Veteran, and civilian communities. Applications must be both innovation- and impact-based. FY21 ERP IDA Focus Areas: The Focus Areas below are specific to the FY21 ERP IDA. Applicants to the FY21 ERP IDA should select one of the Focus Areas below; however, an application that proposes research outside of these FY21 ERP IDA Focus Areas is acceptable, as long as the applicant provides a strong justification.  Innovative Research: Tools intended to better inform or improve upon how PTE research can be performed: ○ Hardware and/or software platforms that will improve seizure detection, characterization, or diagnosis ○ Bioinformatics strategies, to include machine learning, that will improve access, annotation, curation and visualization of large and novel datasets from single or multiple sources ○ Development of new models or better characterization of existing etiologically relevant models for PTE ○ Characterization of the circuits involved in PTE ○ Validation of targets related to post-traumatic epileptogenesis or established PTE  Markers and Mechanisms: Identifying markers or mechanisms via preclinical models that address PTE, which may include the following: ○ Biomarkers (acute and chronic) ○ Treatment ○ Prevention ○ Comorbidity  Epidemiology: Epidemiological characterization of PTE following TBI, which may include the following: ○ Risk factors such as demographics, genetics, anatomy, pathology, or type of injury ○ Outcomes including latency to epilepsy, comorbidities, and mortality ○ Pre-existing conditions including psychological and psychiatric risk factors ○ Treatment and healthcare outcomes research ○ Differentiation of PTE and psychogenic non-epileptic seizures  Longitudinal Studies: Studies of the evolution of PTE, which may include the following: ○ Seizure frequency and semiology ○ Demographics, genetics, anatomy, pathology, or type of injury ○ Comorbidities (e.g., depression, functional deficits, sleep…

Category: Science and Technology and other Research and Development.

Applying now

This notice no longer takes applications. Apply under the newer notice, HT942526BCRPCREA2, which is open now.

The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.